OBJECTIVE: To determine the extent to which levels of membrane eicosapentaenoic (EPA)+docosahexaenoic acids (DHA) (the omega-3 index) were associated with depression in patients with acute coronary syndrome (ACS). Depression is associated with worse cardiovascular (CV) outcomes in patients with ACS. Reduced levels of blood cell membrane omega-3 (n-3) fatty acids (FAs), an emerging risk factor for both CV disease and depression, may help to explain the link between depression and adverse CV outcomes. METHODS: We measured membrane FA composition in 759 patients with confirmed ACS. The analysis included not only EPA and DHA but also the n-6 FAs linoleic and arachidonic acids (LA and AA). Depressive symptoms were measured with the Patient Health Questionnaire-9 (PHQ). Multivariable linear regression was used to adjust for demographic and clinical characteristics. RESULTS: There was a significant inverse relationship between the n-3 index and depressive symptoms (PHQ) in the fully adjusted model (p = .034). For every 4.54% point rise in the n-3 index, there was a 1-point decline in depressive symptoms. In contrast to the n-3 FAs, membrane levels of the n-6 FAs LA and AA were not different between depressed and nondepressed ACS patients. CONCLUSION: We found an inverse relationship between the n-3 index and the prevalence of depressive symptoms in patients with ACS. Therefore, this study supports the hypothesis that reduced n-3 FA tissue levels are a common and potentially modifiable link between depression and adverse CV outcomes.
OBJECTIVE: To determine the extent to which levels of membrane eicosapentaenoic (EPA)+docosahexaenoic acids (DHA) (the omega-3 index) were associated with depression in patients with acute coronary syndrome (ACS). Depression is associated with worse cardiovascular (CV) outcomes in patients with ACS. Reduced levels of blood cell membrane omega-3 (n-3) fatty acids (FAs), an emerging risk factor for both CV disease and depression, may help to explain the link between depression and adverse CV outcomes. METHODS: We measured membrane FA composition in 759 patients with confirmed ACS. The analysis included not only EPA and DHA but also the n-6 FAslinoleic and arachidonic acids (LA and AA). Depressive symptoms were measured with the Patient Health Questionnaire-9 (PHQ). Multivariable linear regression was used to adjust for demographic and clinical characteristics. RESULTS: There was a significant inverse relationship between the n-3 index and depressive symptoms (PHQ) in the fully adjusted model (p = .034). For every 4.54% point rise in the n-3 index, there was a 1-point decline in depressive symptoms. In contrast to the n-3 FAs, membrane levels of the n-6 FAs LA and AA were not different between depressed and nondepressed ACS patients. CONCLUSION: We found an inverse relationship between the n-3 index and the prevalence of depressive symptoms in patients with ACS. Therefore, this study supports the hypothesis that reduced n-3 FA tissue levels are a common and potentially modifiable link between depression and adverse CV outcomes.
Authors: A Tanskanen; J R Hibbeln; J Tuomilehto; A Uutela; A Haukkala; H Viinamäki; J Lehtonen; E Vartiainen Journal: Psychiatr Serv Date: 2001-04 Impact factor: 3.084
Authors: Janice K Kiecolt-Glaser; Martha A Belury; Kyle Porter; David Q Beversdorf; Stanley Lemeshow; Ronald Glaser Journal: Psychosom Med Date: 2007-03-30 Impact factor: 4.312
Authors: Robert C Block; William S Harris; Kimberly J Reid; Scott A Sands; John A Spertus Journal: Atherosclerosis Date: 2007-09-17 Impact factor: 5.162
Authors: Jane E Persons; Jennifer G Robinson; Eric M Ammann; William H Coryell; Mark A Espeland; William S Harris; JoAnn E Manson; Jess G Fiedorowicz Journal: Int J Geriatr Psychiatry Date: 2013-12-11 Impact factor: 3.485
Authors: Yurika Otoki; Marie Hennebelle; Anthony J Levitt; Kiyotaka Nakagawa; Walter Swardfager; Ameer Y Taha Journal: Lipids Date: 2017-04-24 Impact factor: 1.880
Authors: Robert M Carney; Kenneth E Freedland; Eugene H Rubin; Michael W Rich; Brian C Steinmeyer; William S Harris Journal: JAMA Date: 2009-10-21 Impact factor: 56.272
Authors: Robert M Carney; Brian C Steinmeyer; Kenneth E Freedland; Eugene H Rubin; Michael W Rich; William S Harris Journal: J Clin Psychiatry Date: 2016-02 Impact factor: 4.384